HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 0.2% of their position (85.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $2.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/30/2025ACC: 0001193125-25-336619
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-85.00
Net shares
Net seller
$2.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
85.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−85.00
Price / share
$34.38
Trade value
$2.92K
% of position
0.2%
12/29/2025
50.53K→50.45K
Total
Net shares
−85.00
Net value
-$2.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/29/2025 | S · Sale | −85.00 | $34.38 | $2.92K | 0.2% | 50.53K | 50.45K |
| Total | −85.00 | -$2.92K | ||||||
Derivative Transactions0
No derivative transactions reported